ChemFeeds Site Navigation:
Journal Selection:
Search:

99) BKM120 Activity in FDC-FL Cross-talk (Clinical Cancer Research) Tuesday July 1st 2014


100) PD-L1 in BRAF-Mutant, NRAS-Mutant, and Wild-Type Melanoma (Clinical Cancer Research) Tuesday July 1st 2014


101) Sirt7 Promotes Colorectal Cancer Tumorigenesis (Clinical Cancer Research) Tuesday July 1st 2014


102) Contact Guidance Controls T-cell Migration in PDAC (Clinical Cancer Research) Tuesday July 1st 2014


103) MET in Papillary RCC (Clinical Cancer Research) Tuesday July 1st 2014


104) Identification of T-cell Antigens by Minigene Screening (Clinical Cancer Research) Tuesday July 1st 2014


105) NK Infusions as Cancer Therapy (Clinical Cancer Research) Tuesday July 1st 2014


106) Niches in Metastatic Dormancy (Clinical Cancer Research) Tuesday July 1st 2014


107) CDK4 Inhibitors (Clinical Cancer Research) Tuesday July 1st 2014


108) Blocking and Randomization for Biomarker Discovery (Clinical Cancer Research) Tuesday July 1st 2014


109) FDA Clinical Investigator Inspections (Clinical Cancer Research) Tuesday July 1st 2014


110) MET in Papillary Renal Cell Carcinoma (Clinical Cancer Research) Tuesday July 1st 2014


111) Retraction: Molecular Analysis of Non-Small Cell Lung Cancer Identifies Subsets with Different Sensitivity to Insulin-like Growth Factor I Receptor Inhibition (Clinical Cancer Research) Friday June 13th 2014


112) Relative Lymphocyte Count as a Biomarker for Survival with Catumaxomab (Clinical Cancer Research) Friday June 13th 2014


113) miR-31-3p Expression and PFS in Patients with mCRC (Clinical Cancer Research) Friday June 13th 2014


114) Somatic Mutations and Clinical Outcome in Melanoma Samples (Clinical Cancer Research) Friday June 13th 2014


115) KRAS-LCS6 Polymorphism in Stage III Colon Cancer (Clinical Cancer Research) Friday June 13th 2014


116) Four-Gene Blood Panel Predicts Survival after Tremelimumab (Clinical Cancer Research) Friday June 13th 2014


117) FGFR1 Expression Predicts FGFR1-Dependent Lung Cancer (Clinical Cancer Research) Friday June 13th 2014


118) Erlotinib, Erlotinib-Sulindac versus Placebo in Operable HNSCC (Clinical Cancer Research) Friday June 13th 2014


119) Biomarkers of Residual Disease in Ovarian Cancer (Clinical Cancer Research) Friday June 13th 2014


120) SNPs Associated with the Prognosis of Stage I NSCLC (Clinical Cancer Research) Friday June 13th 2014


121) CHFR Methylation Predicts Prognosis in Colorectal Cancer (Clinical Cancer Research) Friday June 13th 2014


122) Initial FDG-PET/CT and Involved sFLC in Solitary Plasmacytoma (Clinical Cancer Research) Friday June 13th 2014


123) PET/MRI in Primary Prostate Cancer (Clinical Cancer Research) Friday June 13th 2014


124) Prognostic Markers of NMIBC (Clinical Cancer Research) Friday June 13th 2014


125) Chloroquine Inhibits Breast Cancer (Clinical Cancer Research) Friday June 13th 2014


126) Synthetic Lethality of PIM1 and PLK1 Inhibition (Clinical Cancer Research) Friday June 13th 2014


127) Niclosamide Overcomes Resistance to Enzalutamide (Clinical Cancer Research) Friday June 13th 2014


128) Anti-EGFR Radioimmunotherapy in Pancreatic Cancer (Clinical Cancer Research) Friday June 13th 2014


129) DUB Inhibitor RA-9 as Ovarian Cancer Therapy (Clinical Cancer Research) Friday June 13th 2014


130) Autophagy Inhibition Enhances Efficacy of Epirubicin in TNBC (Clinical Cancer Research) Friday June 13th 2014


131) Inhibition of RTKs and mTOR in MPNST (Clinical Cancer Research) Friday June 13th 2014


132) Everolimus Binds to and Inhibits Carboxylesterase (Clinical Cancer Research) Friday June 13th 2014


133) Hypomethylated and Induced Genes as Anticancer Drug Targets (Clinical Cancer Research) Friday June 13th 2014


134) MicroRNAs at 14q32 Are Prognostic in Lung Adenocarcinoma (Clinical Cancer Research) Friday June 13th 2014


135) GM-CSF in Colorectal Cancer (Clinical Cancer Research) Friday June 13th 2014


136) Oncogene Fusions in Invasive Mucinous Lung Adenocarcinoma (Clinical Cancer Research) Friday June 13th 2014


137) EZH2 Mutations in Follicular Lymphoma (Clinical Cancer Research) Friday June 13th 2014


138) Bone Metastasis and Muscle Weakness (Clinical Cancer Research) Friday June 13th 2014


139) Protein Turnover: New Targets for Cancer Treatment (Clinical Cancer Research) Friday June 13th 2014


140) PI3K Phosphatases in Prognosis and Therapy (Clinical Cancer Research) Friday June 13th 2014


141) New Strategies in Ewing Sarcoma (Clinical Cancer Research) Friday June 13th 2014


142) Manipulating the Epigenome in Germinal Center Lymphomas (Clinical Cancer Research) Friday June 13th 2014


143) Correction: Induction of Cell Cycle Arrest and Apoptosis by the Proteasome Inhibitor PS-341 in Hodgkin Disease Cell Lines Is Independent of Inhibitor of Nuclear Factor-{kappa}B Mutations or Activation of the CD30, CD40, and RANK Receptors (Clinical Cancer Research) Friday May 30th 2014


144) Prognostic Impact of Specific KRAS Mutations in Colon Cancer (Clinical Cancer Research) Friday May 30th 2014


145) ERK Pathway and Response to Cetuximab-Containing Therapy (Clinical Cancer Research) Friday May 30th 2014


146) Phase II Results of Dovitinib in Renal Cell Carcinoma (Clinical Cancer Research) Friday May 30th 2014


147) Adjuvant CIK Treatment of TNBC (Clinical Cancer Research) Friday May 30th 2014


148) miR-135b for Colorectal Cancer Diagnosis (Clinical Cancer Research) Friday May 30th 2014


149) Diffusion-Weighted MRI for Lymphoma Staging (Clinical Cancer Research) Friday May 30th 2014


150) Estrogen-Related Genes and Prostate Cancer Prognostic Stratification (Clinical Cancer Research) Friday May 30th 2014


151) Antitumor Activity of Cabozantinib in HCC (Clinical Cancer Research) Friday May 30th 2014


152) Ganitumab Inhibits IGF-II-Dependent Ovarian Cancer Models (Clinical Cancer Research) Friday May 30th 2014


153) Cetuximab Resistance and HRAS Oncogenic Mutations in HNSCC (Clinical Cancer Research) Friday May 30th 2014


154) Zoledronic Acid in the Pre- and Postmenopausal Setting (Clinical Cancer Research) Friday May 30th 2014


155) Chimeric HER2 Vaccines Overcome Cancer Patient's T-cell Dysfunction (Clinical Cancer Research) Friday May 30th 2014


156) Driver Mutations in IDH1-Mutant Gliomas (Clinical Cancer Research) Friday May 30th 2014


157) IL-17A Modulates Change of CTCs and Affects Metastases (Clinical Cancer Research) Friday May 30th 2014


158) Cross-Species Oral Carcinoma Genomic Analysis (Clinical Cancer Research) Friday May 30th 2014


159) CD14+ and PD1+ Prognostic in Follicular Lymphoma (Clinical Cancer Research) Friday May 30th 2014


160) CADM1 versus CD7 Plot in HTLV-I Disease Progression (Clinical Cancer Research) Friday May 30th 2014


161) Variants of Prostate Cancer (Clinical Cancer Research) Friday May 30th 2014


162) ALK1 and VEGF Inhibition: A Promising New Combination (Clinical Cancer Research) Friday May 30th 2014


163) Platinum Drug Immunogenicity (Clinical Cancer Research) Friday May 30th 2014


164) Analysis Plans in Phase III Trials with Biomarkers (Clinical Cancer Research) Friday May 30th 2014


165) Postmenopausal Bone Loss as Fuel for Metastatic Cancer (Clinical Cancer Research) Friday May 30th 2014


166) P95 Cutoff Confirmation in Trastuzumab-Treated Breast Cancer (Clinical Cancer Research) Friday May 16th 2014


167) Ficlatuzumab in Solid Tumor Patients with Liver Metastases (Clinical Cancer Research) Friday May 16th 2014


168) Bevacizumab PK/PD in Children (Clinical Cancer Research) Friday May 16th 2014


169) PD-L1 mRNA Positivity and Outcome in Breast Cancer (Clinical Cancer Research) Friday May 16th 2014


170) Stromal-Response Signature in Cancer (Clinical Cancer Research) Friday May 16th 2014


171) Repeatability of FDG-PET/CT in Recurrent Ovarian Cancer (Clinical Cancer Research) Friday May 16th 2014


172) Inhibition of PDGFR{alpha} in Uterine Cancer (Clinical Cancer Research) Friday May 16th 2014


173) Temozolomide Prevention of Breast Cancer Brain Metastases (Clinical Cancer Research) Friday May 16th 2014


174) Metformin Sensitizes EGFR-TKI-Resistant Human Lung Cancer Cells (Clinical Cancer Research) Friday May 16th 2014


175) Determinants of Glioblastoma Response to ABT-888 (Clinical Cancer Research) Friday May 16th 2014


176) Anti-VEGF Antibodies Mitigate Radiation Necrosis in Brain (Clinical Cancer Research) Friday May 16th 2014


177) Targeting Cytomegalovirus Antigens for GBM Immunotherapy (Clinical Cancer Research) Friday May 16th 2014


178) JAK2 Inhibition in cHL and MLBCL (Clinical Cancer Research) Friday May 16th 2014


179) Celecoxib Sensitizes Lymphoma B Cells to Apoptosis (Clinical Cancer Research) Friday May 16th 2014


180) Id1-IGF-II-IGF-IR-AKT Signaling and Targeted Cancer Therapy (Clinical Cancer Research) Friday May 16th 2014


181) Detecting Plasma Tumor DNA in Early-Stage Breast Cancer (Clinical Cancer Research) Friday May 16th 2014


182) MiR-200c Regulates CRC Stemness, Growth, Metastasis by Sox2 (Clinical Cancer Research) Friday May 16th 2014


183) miR-141 Inhibits Proliferation and Metastasis in RCC (Clinical Cancer Research) Friday May 16th 2014


184) Site-Specific Antigen Expression in Human Melanoma (Clinical Cancer Research) Friday May 16th 2014


185) FOXM1 Regulates the Warburg Effect (Clinical Cancer Research) Friday May 16th 2014


186) Pharmacodynamic Biomarkers (Clinical Cancer Research) Friday May 16th 2014


187) Implementing PD Assays in Multiple Laboratories (Clinical Cancer Research) Friday May 16th 2014


188) In Vivo Imaging of Drugs (Clinical Cancer Research) Friday May 16th 2014


189) Circulating Tumor Cells (Clinical Cancer Research) Friday May 16th 2014


190) GWAS in Cancer Pharmacogenomics (Clinical Cancer Research) Friday May 16th 2014


191) Germline PD PGx (Clinical Cancer Research) Friday May 16th 2014


192) PD Biomarkers in Cancer Medicine (Clinical Cancer Research) Friday May 16th 2014


193) The Language of Pharmacodynamics (Clinical Cancer Research) Friday May 16th 2014


194) Adaptive Response to Kinase Inhibition (Clinical Cancer Research) Friday May 16th 2014


195) Metformin in Breast Cancer (Clinical Cancer Research) Friday May 16th 2014


196) Liquid Biopsies for Early Breast Cancers (Clinical Cancer Research) Friday May 16th 2014


View: prev | next

#RealTimeChem:

Announcements:


Mitch Andre Garcia's Chem Feeds 2008-present

Some images have been reproduced by permission of The Royal Society of Chemistry. (RSC' RSS Policy)
Other images have been reproduced with permission of the American Chemical Society. (ACS' RSS Policy)
Few images have been reproduced with pending permission of Wiley-VCH. ()